Cite
HARVARD Citation
Guida, A. et al. (n.d.). 2626 Efficacy and safety of axitinib as third line therapy in metastatic renal cell carcinoma (mRCC): Retrospective analysis. European journal of cancer. pp. S521-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Guida, A. et al. (n.d.). 2626 Efficacy and safety of axitinib as third line therapy in metastatic renal cell carcinoma (mRCC): Retrospective analysis. European journal of cancer. pp. S521-. [Online].